Skip to main content
webinar register page
Topic
The New Rules of 340B Contract Pharmacy
Description
Join 340B Report for its first-ever webinar on May 18 from 1:30 PM—3:00 PM ET to learn more about 340B ESP, its recently updated terms of use, its claims submission process, and more.
Our objective is not to debate the current legal dispute between the federal government and drug manufacturers. Rather, it is to help entities understand and possibly make tough choices they have never faced before.
You will hear from—and be able to pose questions to—a range of 340B stakeholders including:
• Aaron Vandervelde, Founder and Business Development Lead, 340B ESP
• Jason Atlas, Vice President, 340B Enterprise Strategy & Solutions, AmerisourceBergen
• Ashley Mains Espinosa, V.P. of Clinical Operations, DocStation and Co-founder, The 340B Collaborative
• Sue Veer, President and CEO, Carolina Health Centers
• Ted Slafsky, Publisher and Chief Executive Officer, 340B Report
This complimentary event is exclusively for 340B Report paid subscribers and sponsors. If your organization is not a paid subscriber (i.e. you do not have a user license), sign up now at a special 25% discount using code 340BWebinar25 at https://340breport.com/subscribe/. The special discount is available for first-time subscribers only. Free trial subscribers cannot attend the webinar unless they pay for a subscription prior to registration.
Space is limited. Please register by May 16. Questions? Email reshma.eggleston@340breport.com.
Time
May 18, 2022 01:30 PM in
Eastern Time (US and Canada)
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host:
.
×
Share via Email
All fields are required
Your Information
Send to
Message preview
Hi there, You are invited to a Zoom webinar. When: May 18, 2022 01:30 PM Eastern Time (US and Canada) Topic: The New Rules of 340B Contract Pharmacy Register in advance for this webinar: https://zoom.us/webinar/register/WN_fq05tIY7Qbyq2hMlvSFc2A After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Aaron Vandervelde (Founder and Business Development Lead, Managing Director @340B ESP, Berkeley Research Group, LLC) Aaron Vandervelde is Founder and Business Development Lead of 340B ESP™, a technology platform operated by Second Sight Solutions that enables pharmaceutical manufacturers to address ineligible rebates through the collection of 340B contract pharmacy claims. He also serves as a Managing Director in BRG’s Health Analytics practice and has over fifteen years of experience providing strategy, health policy and litigation consulting services to clients in the healthcare industry. Mr. Vandervelde’s practice is focused on clients across the healthcare continuum, including Fortune 500 health insurers, pharmaceutical manufacturers and biotech companies, PBMs, and others. He has advised clients in a variety of federal investigations, contract disputes, litigation, and strategic health policy analyses. Jason Atlas (Vice President, 340B Enterprise Strategy & Solutions @AmerisourceBergen) Jason Atlas is Vice President of 340B Enterprise Strategy & Solutions at AmerisourceBergen (AB), one of the world’s largest health care distributors. Mr. Atlas has more than 20 years of experience in pharmacy leadership and providing 340B guidance. Mr. Atlas serves as the company’s foremost expert on 340B policy, market dynamics and trends. Prior to AB, Mr. Atlas served as the Manager of 340B Education and Compliance Support at Apexus, where he was responsible for developing and growing partnerships with 340B stakeholders, leading projects that required collaboration with the Health Resources & Services Administration (HRSA) and served as an educator at 340B University and other national conferences. Before Apexus, Mr. Atlas spent nearly five years with Denver Health serving as the Director of Outpatient and Ambulatory Pharmacy and other roles. Sue Veer (President and CEO @Carolina Health Centers, Inc.) Sue Veer has served as the President and CEO for Carolina Health Centers, Inc. (CHC) since 2006. She has significant expertise related to health center 340B pharmacy programs. She has served as Chair of the National Association of Community Health Center’s 340B Work Group since 2014. During this period, she has presented 340B training programs for community health centers in 22 states, participated as a lead contributor to the development of the NACHC 340B Compliance Manual, and provided consulting services to individual health centers. Sue has testified on behalf of community health centers at 340B hearings convened by both U.S. Senate and House committees. Ashley Mains Espinosa (VP, Clinical Operations, Co-founder @DocStation, The 340B Collaborative) Ashley Mains Espinosa, PharmD, MS, CPHIMS, FASHP, hails from Denver, Colorado. She is a third generation pharmacist with more than fifteen years of pharmacy experience. She'd held several positions throughout her career from front-line provider to health system pharmacy executive covering areas urban and rural. Dr. Mains Espinosa is currently VP of Clinical Operations at DocStation, a pharmacy technology platform. Ashley has experience helping 340B pharmacies and covered entities of all types thrive through their opportunities and challenges. She is a founder of the 340B Collaborative, the nation's largest covered entity-only free support community. Ted Slafsky (Publisher and Chief Executive Officer @340B Report) Ted Slafsky, Publisher and Chief Executive Officer of 340B Report, is a long-time healthcare thought leader and journalist. Slafsky, Founder & Principal of Wexford Solutions LLC, has three decades of experience in 340B and journalism. He began his career as an award-winning reporter and researcher at U.S News & World Report. He then served in senior leadership for 22 years at 340B Health, a Washington D.C.-based association of over 1400 hospitals and health systems in the 340B program. He started as executive director and then was elevated to President & CEO. During his tenure, he co-founded and led the 340B Coalition, an umbrella group of national organizations representing 340B providers.
×
Switch Time Zone
Time Zone:
(GMT-11:00) Midway Island, Samoa
(GMT-11:00) Pago Pago
(GMT-10:00) Hawaii
(GMT-8:00) Alaska
(GMT-8:00) Juneau
(GMT-7:00) Vancouver
(GMT-7:00) Pacific Time (US and Canada)
(GMT-7:00) Tijuana
(GMT-7:00) Arizona
(GMT-7:00) Yukon
(GMT-6:00) Edmonton
(GMT-6:00) Mountain Time (US and Canada)
(GMT-6:00) Mazatlan
(GMT-6:00) Saskatchewan
(GMT-6:00) Guatemala
(GMT-6:00) El Salvador
(GMT-6:00) Managua
(GMT-6:00) Costa Rica
(GMT-6:00) Tegucigalpa
(GMT-6:00) Chihuahua
(GMT-5:00) Winnipeg
(GMT-5:00) Central Time (US and Canada)
(GMT-5:00) Mexico City
(GMT-5:00) Panama
(GMT-5:00) Bogota
(GMT-5:00) Lima
(GMT-5:00) Monterrey
(GMT-5:00) Acre
(GMT-4:00) Montreal
(GMT-4:00) Eastern Time (US and Canada)
(GMT-4:00) Indiana (East)
(GMT-4:00) Puerto Rico
(GMT-4:00) Caracas
(GMT-4:00) Santiago
(GMT-4:00) La Paz
(GMT-4:00) Guyana
(GMT-3:00) Halifax
(GMT-3:00) Montevideo
(GMT-3:00) Recife
(GMT-3:00) Buenos Aires, Georgetown
(GMT-3:00) Sao Paulo
(GMT-3:00) Atlantic Time (Canada)
(GMT-2:30) Newfoundland and Labrador
(GMT-2:00) Greenland
(GMT-2:00) Fernando de Noronha
(GMT-1:00) Cape Verde Islands
(GMT+0:00) Azores
(GMT+0:00) Universal Time UTC
(GMT+0:00) Greenwich Mean Time
(GMT+0:00) Reykjavik
(GMT+0:00) Nouakchott
(GMT+1:00) Dublin
(GMT+1:00) London
(GMT+1:00) Lisbon
(GMT+1:00) Casablanca
(GMT+1:00) West Central Africa
(GMT+1:00) Algiers
(GMT+1:00) Tunis
(GMT+2:00) Belgrade, Bratislava, Ljubljana
(GMT+2:00) Sarajevo, Skopje, Zagreb
(GMT+2:00) Oslo
(GMT+2:00) Copenhagen
(GMT+2:00) Brussels
(GMT+2:00) Amsterdam, Berlin, Rome, Stockholm, Vienna
(GMT+2:00) Amsterdam
(GMT+2:00) Rome
(GMT+2:00) Stockholm
(GMT+2:00) Vienna
(GMT+2:00) Luxembourg
(GMT+2:00) Paris
(GMT+2:00) Zurich
(GMT+2:00) Madrid
(GMT+2:00) Harare, Pretoria
(GMT+2:00) Warsaw
(GMT+2:00) Prague Bratislava
(GMT+2:00) Budapest
(GMT+2:00) Tripoli
(GMT+2:00) Cairo
(GMT+2:00) Johannesburg
(GMT+2:00) Khartoum
(GMT+3:00) Helsinki
(GMT+3:00) Nairobi
(GMT+3:00) Sofia
(GMT+3:00) Istanbul
(GMT+3:00) Athens
(GMT+3:00) Bucharest
(GMT+3:00) Nicosia
(GMT+3:00) Beirut
(GMT+3:00) Damascus
(GMT+3:00) Jerusalem
(GMT+3:00) Amman
(GMT+3:00) Moscow
(GMT+3:00) Baghdad
(GMT+3:00) Kuwait
(GMT+3:00) Riyadh
(GMT+3:00) Bahrain
(GMT+3:00) Qatar
(GMT+3:00) Aden
(GMT+3:00) Djibouti
(GMT+3:00) Mogadishu
(GMT+3:00) Kiev
(GMT+3:00) Minsk
(GMT+3:00) Chisinau
(GMT+4:00) Dubai
(GMT+4:00) Muscat
(GMT+4:00) Baku, Tbilisi, Yerevan
(GMT+4:30) Tehran
(GMT+4:30) Kabul
(GMT+5:00) Yekaterinburg
(GMT+5:00) Islamabad, Karachi, Tashkent
(GMT+5:30) India
(GMT+5:30) Mumbai, Kolkata, New Delhi
(GMT+5:30) Colombo
(GMT+5:45) Kathmandu
(GMT+6:00) Almaty
(GMT+6:00) Dacca
(GMT+6:00) Astana, Dhaka
(GMT+6:30) Rangoon
(GMT+7:00) Novosibirsk
(GMT+7:00) Krasnoyarsk
(GMT+7:00) Bangkok
(GMT+7:00) Vietnam
(GMT+7:00) Jakarta
(GMT+8:00) Irkutsk, Ulaanbaatar
(GMT+8:00) Beijing, Shanghai
(GMT+8:00) Hong Kong SAR
(GMT+8:00) Taipei
(GMT+8:00) Kuala Lumpur
(GMT+8:00) Singapore
(GMT+8:00) Perth
(GMT+9:00) Yakutsk
(GMT+9:00) Seoul
(GMT+9:00) Osaka, Sapporo, Tokyo
(GMT+9:30) Darwin
(GMT+9:30) Adelaide
(GMT+10:00) Vladivostok
(GMT+10:00) Guam, Port Moresby
(GMT+10:00) Brisbane
(GMT+10:00) Canberra, Melbourne, Sydney
(GMT+10:00) Hobart
(GMT+10:30) Lord Howe IsIand
(GMT+11:00) Magadan
(GMT+11:00) Solomon Islands
(GMT+11:00) New Caledonia
(GMT+12:00) Kamchatka
(GMT+12:00) Fiji Islands, Marshall Islands
(GMT+12:00) Auckland, Wellington
(GMT+13:00) Independent State of Samoa
×
Continue to PayPal
Click to Continue
×
×
Upcoming Meetings
Would you like to start this meeting?
Would you like to start one of these meetings?
View more...